Insmed To Present at the 44th Annual J.P. Morgan Healthcare Conference

Insmed (Nasdaq: INSM) said management will present at the 44th Annual J.P.

Rhea-AI Summary

Insmed (Nasdaq: INSM) said management will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 12, 2026 at 3:00 p.m. PT / 6:00 p.m. ET. The presentation will be webcast live and available via the company’s investor relations website. Webcasts will be archived for 30 days after the live event.

Argus Jan 2 session

+1.77% close to close Open Argus

Details

News Market Reaction – INSM

On Jan 2, the day this news came out, INSM closed 1.77% above the previous close.

Data tracked by StockTitan Argus for the Jan 2 session.

Key Figures

Conference date: January 12, 2026 Presentation time: 3:00 p.m. PT / 6:00 p.m. ET Webcast archive period: 30 days

Conference date

January 12, 2026

J.P. Morgan 2026 Healthcare Conference presentation date

Presentation time

3:00 p.m. PT / 6:00 p.m. ET

Scheduled time for Insmed presentation

Webcast archive period

30 days

Duration webcasts remain available after event

Historical Context

5 past events · Latest: Dec 17

5 events

1. Dec 17

   Clinical trial update

   24h Move

   -1.1%

   Phase 2b BiRCh CRSsNP study failed endpoints and program discontinued.

2. Dec 09

   Scientific meeting data

   24h Move

   -1.2%

   Multiple ERS 2025 abstracts including TPIP Phase 2b and ASPEN subgroup data.

3. Dec 04

   Equity inducement grants

   24h Move

   -0.8%

   Restricted stock units and options granted to 92 new employees.

4. Nov 18

   EU drug approval

   24h Move

   +2.1%

   European Commission approval of BRINSUPRI for NCFB patients 12 and older.

5. Nov 13

   CSR initiative

   24h Move

   -1.8%

   Fourth annual Global Day of Good with 1,200 employees volunteering worldwide.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BRIDGEWATER, N.J., Jan. 2, 2026 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will present at the J.P. Morgan 2026 Healthcare Conference in San Francisco, on Monday, January 12, 2026, at 3:00 p.m. PT / 6:00 p.m. ET.

This event will be webcast live and can be accessed by visiting the investor relations section of the Company's website at www.insmed.com. Webcasts will be archived for a period of 30 days following the conclusion of the live events.

About Insmed

Insmed Incorporated is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. The Company is advancing a diverse portfolio of approved and mid- to late-stage investigational medicines as well as cutting-edge drug discovery focused on serving patient communities where the need is greatest. Insmed's most advanced programs are in pulmonary and inflammatory conditions, including two approved therapies to treat chronic, debilitating lung diseases. The Company's early-stage programs encompass a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue.

Headquartered in Bridgewater, New Jersey, Insmed has offices and research locations throughout the United States, Europe, and Japan. Insmed is proud to be recognized as one of the best employers in the biopharmaceutical industry, including spending five consecutive years as the No. 1 Science Top Employer. Visit www.insmed.com to learn more or follow us on LinkedIn, Instagram, YouTube, and X.

Contact:

Investors:

Bryan Dunn
Vice President, Investor Relations
(646) 812-4030
investor.relations@insmed.com

Media:

Claire Mulhearn
Vice President, Corporate Communications
(862) 842-6819
media@insmed.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-to-present-at-the-44th-annual-jp-morgan-healthcare-conference-302648267.html

SOURCE Insmed Incorporated

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Insmed (INSM) present at the J.P. Morgan 2026 Healthcare Conference?

Insmed management will present on January 12, 2026 at 3:00 p.m. PT / 6:00 p.m. ET.

How can I watch Insmed's (INSM) J.P. Morgan presentation on January 12, 2026?

The presentation will be webcast live and accessible via the company’s investor relations website at www.insmed.com.

Will Insmed's (INSM) J.P. Morgan webcast be available after the live event?

Yes, the webcast will be archived for 30 days following the conclusion of the live event.

What is the J.P. Morgan Healthcare Conference session time for Insmed (INSM) in ET?

The session is scheduled for 6:00 p.m. ET on January 12, 2026.

Where on Insmed's website can investors find the J.P. Morgan webcast for INSM?

Investors can find the live webcast and archive in the Investor Relations section at www.insmed.com.

Is there any published financial data tied to Insmed's (INSM) J.P. Morgan presentation on January 12, 2026?

The announcement only confirms the presentation date, time, and webcast; no financial figures were disclosed.